Monthly Prescribing Reference: Systolic BP Target of Less Than 120 mm Hg Favored for Most Participants in BP Trial Net benefits of treatment were compared across categories of age, SPRINT-derived frailty status, and polypharmacy. HealthDay News — Most older adults in the Systolic Blood Pressure Intervention Trial ... Systolic BP Target of Less Than 120 mm Hg Favored for Most Participants in BP Trial Losing weight can definitely help lower blood pressure.

Understanding the Context

Research shows that losing about 11 pounds (5 kilograms) reduces systolic blood pressure by roughly 4 to 5 mm Hg on average. The American Heart ... Monthly Prescribing Reference: Baxdrostat Reduces Seated Systolic BP in Uncontrolled, Resistant Hypertension The change from baseline in the least-squares mean seated systolic blood pressure at 12 weeks was −14.5, −15.7, and −5.8 mm Hg with 1mg-, 2mg baxdrostat, and placebo, respectively. HealthDay News — ...

Key Insights

Automated BP monitoring (with multiple readings taken while the patient is resting) is more accurate than manual BP monitoring in primary care patients with systolic hypertension. The results have ... Systolic pressure measures arterial pressure when the heart contracts, with normal readings less than 120 mmHg. Diastolic pressure measures arterial pressure when the heart relaxes, with normal ... TCTMD: Keeping Systolic BP Below 130 May Help Women Live Into Their 90s: WHI Data Maintaining a systolic blood pressure below 130 mm Hg may increase the probability of survival to age 90 in healthy older women, with or without BP-lowering medications, data from the Women’s Health ...

Final Thoughts

Keeping Systolic BP Below 130 May Help Women Live Into Their 90s: WHI Data Please provide your email address to receive an email when new articles are posted on . Systolic BP was 3.48 mm Hg lower in the intervention group vs. the control group. Decreased sitting could be a ... Healio: SEISMiC topline results: Istaroxime improves systolic BP profile in cardiogenic shock Please provide your email address to receive an email when new articles are posted on . In the phase 2 SEISMiC trial, istaroxime met its primary endpoint of improving systolic BP profile at 6 hours in ...

Renal & Urology News: Lorundrostat Reduces Systolic Blood Pressure in Patients With Hypertension and CKD